% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gunkel:119334,
author = {M. Gunkel and I. Chung$^*$ and S. Wörz$^*$ and K. Deeg$^*$
and R. Simon and G. Sauter and D. Jones$^*$ and A.
Korshunov$^*$ and K. Rohr$^*$ and H. Erfle and K. Rippe$^*$},
title = {{Q}uantification of telomere features in tumor tissue
sections by an automated 3{D} imaging-based workflow.2},
journal = {Methods},
volume = {114},
issn = {1046-2023},
address = {Orlando, Fla.},
publisher = {Academic Press},
reportid = {DKFZ-2017-00089},
pages = {60 - 73},
year = {2017},
abstract = {The microscopic analysis of telomere features provides a
wealth of information on the mechanism by which tumor cells
maintain their unlimited proliferative potential.
Accordingly, the analysis of telomeres in tissue sections of
patient tumor samples can be exploited to obtain diagnostic
information and to define tumor subgroups. In many
instances, however, analysis of the image data is conducted
by manual inspection of 2D images at relatively low
resolution for only a small part of the sample. As the
telomere feature signal distribution is frequently
heterogeneous, this approach is prone to a biased selection
of the information present in the image and lacks
subcellular details. Here we address these issues by using
an automated high-resolution imaging and analysis workflow
that quantifies individual telomere features on tissue
sections for a large number of cells. The approach is
particularly suited to assess telomere heterogeneity and low
abundant cellular subpopulations with distinct telomere
characteristics in a reproducible manner. It comprises the
integration of multi-color fluorescence in situ
hybridization, immunofluorescence and DNA staining with
targeted automated 3D fluorescence microscopy and image
analysis. We apply our method to telomeres in glioblastoma
and prostate cancer samples, and describe how the imaging
data can be used to derive statistically reliable
information on telomere length distribution or
colocalization with PML nuclear bodies. We anticipate that
relating this approach to clinical outcome data will prove
to be valuable for pretherapeutic patient stratification.},
cin = {B066 / B080 / B062 / G380},
ddc = {540},
cid = {I:(DE-He78)B066-20160331 / I:(DE-He78)B080-20160331 /
I:(DE-He78)B062-20160331 / I:(DE-He78)G380-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:27725304},
doi = {10.1016/j.ymeth.2016.09.014},
url = {https://inrepo02.dkfz.de/record/119334},
}